Novel 3-arylethynyl-substituted thieno[3,4-b]pyrazine derivatives as human transglutaminase 2 inhibitors

  • Nayeon Kim
  • , Se Hun Kwak
  • , Seon Hyeong Lee
  • , Vinayak Juvekar
  • , Byung Il Lee
  • , Hee Chul Ahn
  • , Soo Youl Kim
  • , Young Dae Gong

Research output: Contribution to journalArticlepeer-review

7 Scopus citations

Abstract

In the process of optimization, we developed a novel core skeleton of thieno[3,4-b]pyrazine viaGK-13. The derivatives synthesized were shown to inhibit TGase 2 activity in cancer cells. Some of the hit compounds such as the arylethynyl group-coupled thieno[3,4-b]pyrazine derivatives were shown to exhibit promising activity for use as potential therapeutic small-molecules in renal cancer by inhibiting TGase 2 activity. This journal is

Original languageEnglish
Pages (from-to)4932-4940
Number of pages9
JournalOrganic and Biomolecular Chemistry
Volume12
Issue number27
DOIs
StatePublished - 21 Jul 2014

Fingerprint

Dive into the research topics of 'Novel 3-arylethynyl-substituted thieno[3,4-b]pyrazine derivatives as human transglutaminase 2 inhibitors'. Together they form a unique fingerprint.

Cite this